CNS LYMPHOMA
Clinical trials for CNS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CNS LYMPHOMA trials appear
Sign up with your email to follow new studies for CNS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive therapy targets Hard-to-Treat brain cancer
Disease control Recruiting nowThis study tests a new radioactive drug called [90Y]Y-PentixaTher for people with central nervous system (CNS) lymphoma that has returned or not responded to other treatments. About 15 participants will receive one intravenous dose at different strength levels to find the safest …
Matched conditions: CNS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Pentixapharm AG • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New cocktail targets brain lymphoma: early trial seeks safer control
Disease control Recruiting nowThis early-phase study tests whether adding zanubrutinib to a standard chemotherapy regimen (Pola-R-CHP plus high-dose methotrexate) is safe for people whose large B-cell lymphoma has spread to the brain or spinal cord. About 20 adults will take part. The main goal is to find sid…
Matched conditions: CNS LYMPHOMA
Phase: PHASE1 • Sponsor: Juan P. Alderuccio, MD • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Dual-Target CAR t cells take on tough lymphoma
Disease control Recruiting nowThis early-phase study tests a new type of cell therapy (CD19x22 CAR T) for adolescents and adults with B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified to target two proteins on cancer cells. Th…
Matched conditions: CNS LYMPHOMA
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 22, 2026 14:03 UTC